Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 5:28 pm Purchase | 2025-04-10 | 13G | Outlook Therapeutics, Inc. OTLK | Sphera Funds Management Ltd. | 2,571,426 7.490% | 857,142 (+50.00%) | Filing History |
| 2025-04-10 5:27 pm Purchase | 2025-03-31 | 13G | Skye Bioscience, Inc. SKYE | Sphera Funds Management Ltd. | 1,476,353 4.770% | 174,835 (+13.43%) | Filing History |
| 2025-04-10 5:25 pm Sale | 2025-03-31 | 13G | Chemomab Therapeutics Ltd. CMMB | Sphera Funds Management Ltd. | 900,428 4.780% | -314,147 (-25.86%) | Filing History |
| 2025-03-03 3:58 pm Purchase | 2025-01-17 | 13G | Outlook Therapeutics, Inc. OTLK | Sphera Funds Management Ltd. | 1,714,284 5.210% | 1,714,284 (New Position) | Filing History |
| 2024-11-04 12:05 pm Purchase | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | Sphera Funds Management Ltd. | 189,270 1.250% | 189,270 (New Position) | Filing History |
| 2024-08-20 2:36 pm Purchase | 2024-07-25 | 13G | Chemomab Therapeutics Ltd. CMMB | Sphera Funds Management Ltd. | 1,214,575 6.560% | 1,214,575 (New Position) | Filing History |
| 2024-02-08 09:51 am Purchase | 2024-01-29 | 13G | Skye Bioscience, Inc. SKYE | Sphera Funds Management Ltd. | 1,301,518 5.390% | 1,301,518 (New Position) | Filing History |
| 2024-02-05 09:15 am Purchase | 2023-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | Sphera Funds Management Ltd. | 7,130,625 6.390% | 6,561,912 (+1153.82%) | Filing History |
| 2024-02-05 09:13 am Sale | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Sphera Funds Management Ltd. | 328,986 3.740% | -255,303 (-43.69%) | Filing History |
| 2024-02-05 09:12 am Sale | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Sphera Funds Management Ltd. | 1,562,907 2.530% | -533,351 (-25.44%) | Filing History |
| 2024-02-05 09:10 am Purchase | 2023-12-31 | 13G | ProMIS Neurosciences, Inc. PMN | Sphera Funds Management Ltd. | 1,892,474 9.990% | 39,956 (+2.16%) | Filing History |
| 2023-10-10 11:15 am Purchase | 2023-09-27 | 13G | Jasper Therapeutics, Inc. JSPR | Sphera Funds Management Ltd. | 568,713 5.130% | 568,713 (New Position) | Filing History |
| 2023-08-30 09:43 am Purchase | 2023-08-23 | 13G | ProMIS Neurosciences, Inc. PMN | Sphera Funds Management Ltd. | 1,852,518 9.990% | 1,852,518 (New Position) | Filing History |
| 2023-06-27 10:01 am Unchanged | 2023-06-16 | 13G | Praxis Precision Medicines, Inc. PRAX | Sphera Funds Management Ltd. | 584,289 7.350% | 0 (Unchanged) | Filing History |
| 2023-06-22 11:26 am Purchase | 2023-06-16 | 13G | Praxis Precision Medicines, Inc. PRAX | Sphera Funds Management Ltd. | 584,289 7.310% | 584,289 (New Position) | Filing History |
| 2023-03-07 06:01 am Purchase | 2023-03-03 | 13G | Inozyme Pharma, Inc. INZY | Sphera Funds Management Ltd. | 2,096,258 5.190% | 2,096,258 (New Position) | Filing History |
| 2023-02-06 11:27 am Sale | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Sphera Funds Management Ltd. | 16,667 1.990% | -17,221 (-50.82%) | Filing History |
| 2022-02-14 06:15 am Purchase | 2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Sphera Funds Management Ltd. | 33,888 5.100% | 100 (+0.30%) | Filing History |
| 2022-02-14 06:13 am Sale | 2021-12-31 | 13G | Altimmune, Inc. ALT | Sphera Funds Management Ltd. | 1,244,241 3.130% | -2,531,377 (-67.05%) | Filing History |
| 2021-08-31 11:03 am Purchase | 2021-08-26 | 13G | Altimmune, Inc. ALT | Sphera Funds Management Ltd. | 3,775,618 8.840% | 3,775,618 (New Position) | Filing History |